VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Milestone: Qianshi Bio's Class 1 Stem Cell Drug Accepted by CDE, Strengthening China's MSC Pipeline
Milestone: Qianshi Bio's Class 1 Stem Cell Drug Accepted by CDE, Strengthening China's MSC Pipeline
May 18, 2026 16:21 CST Updated May 19, 10:35
Share:
